ArticleSurgery open science2026
Conventional versus enhanced recovery laparoscopic cholecystectomy in Rwanda: A comparative analysis of costs and clinical outcomes.
Article in Surgery open science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Post-Cholecystectomy nutritional management: a comprehensive review of evidence-based guidelines and clinical practice.Frontiers in surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Enhanced Recovery After Surgery (ERAS) protocols improve outcomes in high-income settings, but evidence from low- and middle-income countries (LMICs) is limited. This study compared clinical outcomes and direct healthcare costs between conventional laparoscopic cholecystectomy (CLC) and ERAS-based laparoscopic cholecystectomy (ERAS-LC) in Rwanda. Methods: A prospective before-after cohort study was conducted between January and December 2022 at two tertiary hospitals in Rwanda. A total of 124 adult patients undergoing elective laparoscopic cholecystectomy were included: 70 managed with conventional care and 54 within an ERAS pathway. Clinical outcomes (length of stay, opioid use, time to oral intake, complications) and direct hospital costs were compared. Statistical analyses included chi-square, Results: Groups were similar at baseline. All ERAS patients resumed oral intake on day one versus 87.1% in CLC ( Conclusion: ERAS for laparoscopic cholecystectomy in a resource-limited setting is feasible, safe, and improves recovery while optimizing inpatient resource use. Despite higher medication costs, ERAS reduces LOS, opioid use, and nursing costs, supporting its adoption in LMIC surgical care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.